“Antioxidatant Effect of Atorvastatin and Rosuvastatin in Hyperlipidemic Patients: A Randomized Controlled Trial”, J. Armed Forces Med. Coll., vol. 14, no. 1, pp. 54–58, Aug. 2019, doi: 10.3329/jafmc.v14i1.42723.